Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708, USA.
ACS Nano. 2011 Nov 22;5(11):8532-40. doi: 10.1021/nn201451c. Epub 2011 Oct 25.
The dimerization of receptors on the cell membrane is an important step in the activation of cell signaling pathways. Several methods exist for observing receptor dimerization, including coimmunoprecipitation, chemical cross-linking, and fluorescence resonance energy transfer (FRET). These techniques are limited in that only FRET is appropriate for live cells, but even that method suffers from photobleaching and bleed-through effects. In this study, we implement an alternative method for the targeting of HER-2 homodimer formation based on the plasmonic coupling of gold nanoparticles functionalized with HER-2 Ab. In the presented studies, SK-BR-3 cells, known to overexpress HER-2, are labeled with these nanoparticles and receptor colocalization is observed using plasmonic coupling. HER-2 targeted nanoparticles bound to these cells exhibit a peak resonance that is significantly red-shifted relative to those bound to similar receptors on A549 cells, which have significantly lower levels of HER-2 expression. This significant red shift indicates plasmonic coupling is occurring and points to a new avenue for assessing dimerization by monitoring their colocalization. To determine that dimerization is occurring, the refractive index of the nanoenvironment of the labels is assessed using a theoretical analysis based on the Mie coated sphere model. The results indicate scattering by single, isolated nanoparticles for the low HER-2 expressing A549 cell line, but the scattering observed for the HER-2 overexpressing SK-BR-3 cell line may only be explained by plasmonic-coupling of proximal nanoparticle pairs. To validate the conformation of nanoparticles bound to HER-2 receptors undergoing dimerization, discrete dipole approximation (DDA) models are used to assess spectra of scattering by coupled nanoparticles. Comparison of the experimental results with theoretical models indicates that NP dimers are formed for the labeling of SK-BR-3 cells, suggesting that receptor dimerization has been observed.
细胞膜上受体的二聚化是细胞信号通路激活的重要步骤。有几种方法可用于观察受体二聚化,包括共免疫沉淀、化学交联和荧光共振能量转移(FRET)。这些技术都存在局限性,只有 FRET 适用于活细胞,但即使是这种方法也存在荧光漂白和串扰效应。在这项研究中,我们基于 HER-2 Ab 功能化的金纳米粒子的等离子体耦合,提出了一种针对 HER-2 同源二聚体形成的靶向方法。在本研究中,已知过表达 HER-2 的 SK-BR-3 细胞用这些纳米粒子进行标记,并通过等离子体偶联观察受体的共定位。与 A549 细胞上类似受体结合的这些细胞结合的 HER-2 靶向纳米粒子表现出明显红移的峰共振,而 A549 细胞上的 HER-2 表达水平明显较低。这种明显的红移表明等离子体偶联正在发生,并为通过监测它们的共定位来评估二聚化提供了一条新途径。为了确定二聚化是否发生,使用基于 Mie 涂层球模型的理论分析评估标签纳米环境的折射率。结果表明,对于低表达 HER-2 的 A549 细胞系,单个孤立纳米粒子的散射,但对于过表达 HER-2 的 SK-BR-3 细胞系观察到的散射,只能通过近邻纳米粒子对的等离子体偶联来解释。为了验证经历二聚化的 HER-2 受体结合的纳米粒子的构象,使用离散偶极子近似(DDA)模型来评估偶联纳米粒子的散射光谱。将实验结果与理论模型进行比较表明,对于 SK-BR-3 细胞的标记形成了 NP 二聚体,表明已经观察到受体二聚化。